Chemicalinfo & Chemlink & Pharm-Chem Nethttp://www.chemlink.org/blog/Pharmaceutical Chemical Online BlogRainbowSoft Studio Z-Blog 1.7 Laputa Build 70216zh-CNCopyright 2005-2009 Your WebSite. Some Rights Reserved.Wed, 27 Jan 2010 22:04:10 +08002009年国际一线药企重点研发产品时间表sales@chemlink.org (admin)http://www.chemlink.org/blog/93.Wed, 27 Jan 2010 22:02:37 +0800http://www.chemlink.org/blog/93.Newshttp://www.chemlink.org/blog/93.#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=93http://www.chemlink.org/blog/cmd.asp?act=tb&id=93&key=c59a3a9b治疗白血病的蛋白激酶抑制剂 Bosutinibsales@chemlink.org (admin)http://www.chemlink.org/blog/92.Tue, 26 Jan 2010 10:05:51 +0800http://www.chemlink.org/blog/92.Newshttp://www.chemlink.org/blog/92.#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=92http://www.chemlink.org/blog/cmd.asp?act=tb&id=92&key=97139aaf新型糖尿病药物介绍-维格列汀(vildagliptin)sales@chemlink.org (admin)http://www.chemlink.org/blog/91.Thu, 14 Jan 2010 15:54:39 +0800http://www.chemlink.org/blog/91.Newshttp://www.chemlink.org/blog/91.#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=91http://www.chemlink.org/blog/cmd.asp?act=tb&id=91&key=7f8a3380Cediranib Demonstrates Safe, Well Tolerated Antitumour Activity in Patients With Advanced Renal Cell Carcinomasales@chemlink.org (admin)http://www.chemlink.org/blog/90.Fri, 18 Dec 2009 15:30:13 +0800http://www.chemlink.org/blog/90.Newshttp://www.chemlink.org/blog/90.#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=90http://www.chemlink.org/blog/cmd.asp?act=tb&id=90&key=ac5f1c35美国FDA的委员会同意Asteilas / Cardiome的心律失常药 Vernakalansales@chemlink.org (admin)http://www.chemlink.org/blog/89.Mon, 13 Apr 2009 14:33:42 +0800http://www.chemlink.org/blog/89.Newshttp://www.chemlink.org/blog/89.#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=89http://www.chemlink.org/blog/cmd.asp?act=tb&id=89&key=0344c7a2GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic...sales@chemlink.org (admin)http://www.chemlink.org/blog/88.Mon, 13 Apr 2009 08:28:01 +0800http://www.chemlink.org/blog/88.Sourcehttp://www.chemlink.org/blog/88.#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=88http://www.chemlink.org/blog/cmd.asp?act=tb&id=88&key=b424e195临床研究证明: 达沙替尼(Dasatinib/Sprycel)治疗白血病是一种安全有效药物sales@chemlink.org (admin)http://www.chemlink.org/blog/87.Tue, 24 Mar 2009 08:10:54 +0800http://www.chemlink.org/blog/87.Newshttp://www.chemlink.org/blog/87.#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=87http://www.chemlink.org/blog/cmd.asp?act=tb&id=87&key=2826595aZilmax (Zilpaterol hydrochloride) Offers Extended Marketing Window For Cattle Feederssales@chemlink.org (admin)http://www.chemlink.org/blog/86.Tue, 03 Feb 2009 14:34:01 +0800http://www.chemlink.org/blog/86.Newshttp://www.chemlink.org/blog/86.#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=86http://www.chemlink.org/blog/cmd.asp?act=tb&id=86&key=015276afFDA Approves Gleevec (Imatinib mesylate) to Prevent Recurrence of Rare Gastrointestinal Cancersales@chemlink.org (admin)http://www.chemlink.org/blog/85.Thu, 15 Jan 2009 15:19:43 +0800http://www.chemlink.org/blog/85.Newshttp://www.chemlink.org/blog/85.#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=85http://www.chemlink.org/blog/cmd.asp?act=tb&id=85&key=aa78a540FDA Approves Gleevec (Imatinib mesylate) for Gastrointestinal Stromal Tumorsales@chemlink.org (admin)http://www.chemlink.org/blog/83.Tue, 06 Jan 2009 13:55:33 +0800http://www.chemlink.org/blog/83.Newshttp://www.chemlink.org/blog/83.#commenthttp://www.chemlink.org/blog/http://www.chemlink.org/blog/sydication.asp?cmt=83http://www.chemlink.org/blog/cmd.asp?act=tb&id=83&key=1f43d68a